| Bioactivity | USP7-IN-13 (Compound 101) is a USP7 inhibitor with an IC50 value of 0.2-1 μM, which can be used for the study of multiple myeloma[1]. |
| Target | IC50: 0.2~1 μM (USP7). |
| CAS | 2305046-93-7 |
| Formula | C24H28N4O3 |
| Molar Mass | 420.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Buhrlage, Sara, et al. "Novel usp7 inhibitors for treating multiple myeloma." U.S. Patent. WO2019067503. 2019-04-04 |
USP7-IN-13
CAS: 2305046-93-7 F: C24H28N4O3 W: 420.50
USP7-IN-13 (Compound 101) is a USP7 inhibitor with an IC50 value of 0.2-1 μM, which can be used for the study of multip
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.